DEFA14A: Crinetics Pharmaceuticals Corrects Errors in Proxy Statement for 2025 Annual Meeting

Crinetics Pharmaceuticals issues a supplement to its proxy statement to correct clerical errors regarding the day of the week for the annual meeting and the deadline for stockholder proposals.

Summary

• Crinetics Pharmaceuticals has filed a supplement to its proxy statement for the 2025 Annual Meeting of Stockholders.
• The supplement corrects the day of the week for the Annual Meeting, which was incorrectly stated as Friday, June 11, 2025, and should be Wednesday, June 11, 2025.
• The supplement also corrects the deadline for stockholders intending to solicit proxies in support of director nominees for the 2026 annual meeting, changing it from April 12, 2025, to April 13, 2026.
• All other information in the original proxy statement remains unchanged.

Sentiment

Score: 7

Explanation: The document is a neutral correction of errors, indicating attention to detail and transparency, which is viewed positively.

Positives

• The company is proactively correcting errors in its proxy statement to ensure accurate information for stockholders.

Future Outlook

The document does not contain any specific forward-looking statements beyond the dates of the meetings and deadlines.

Industry Context

This announcement is a routine correction to a proxy statement, a standard part of corporate governance for publicly traded companies.

Stakeholder Impact

• Ensures shareholders have accurate information for voting decisions.

Key Dates

Keywords

Proxy Statement, Annual Meeting, Crinetics Pharmaceuticals, Stockholders, Corrections, Director Nominees